We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 46 results
  1. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration

    Objective

    This study aimed to investigate the role of cholesterol metabolism-related genes in nonfunctioning pituitary neuroendocrine tumors...

    Tianshun Feng, Pengwei Hou, ... Shousen Wang in Lipids in Health and Disease
    Article Open access 10 August 2023
  2. Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor size

    Background

    Erythropoietin-producing hepatocellular (EPH) receptors are the largest known family of receptor tyrosine kinases characterized in humans....

    Hadara Rubinfeld, Zvi R. Cohen, ... Ilan Shimon in Molecular Biology Reports
    Article Open access 11 February 2024
  3. Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia

    Introduction

    Pituitary neuroendocrine tumors (PitNETs) represent 15–18.2% of all intracranial tumors. Their clinical presentation can range from...

    C. E. Jimenez-Canizales, W. Rojas, ... A. Colao in Journal of Endocrinological Investigation
    Article 31 March 2023
  4. Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours

    Non-functioning pituitary tumours (NF-PitNETs) are common intracranial benign neoplasms that can exhibit aggressive behaviour by invading...

    Ashutosh Rai, Soujanya D. Yelamanchi, ... Carles Gaston-Massuet in Acta Neuropathologica Communications
    Article Open access 16 September 2022
  5. Aggressive nonfunctioning pituitary neuroendocrine tumors

    Nonfunctioning pituitary neuroendocrine tumors (NF-PitNETs) are tumors that are not associated with clinical evidence of hormonal hypersecretion....

    Sérgio Portovedo, Leonardo Vieira Neto, ... Leandro Miranda-Alves in Brain Tumor Pathology
    Article 20 June 2022
  6. Differential expression levels of β-catenin are associated with invasive behavior of both functional and non-functional pituitary neuroendocrine tumor (PitNET)

    Background

    Although research continues to elucidate the molecular mechanism underlying pituitary tumor pathogenesis, limited information is available...

    S. Fahimeh Taghavi, Mohammad Ghorbani, ... Masoumeh Tavakoli-Yaraki in Molecular Biology Reports
    Article 16 June 2023
  7. TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours

    Purpose

    Transforming growth factor-beta receptor 3-like (TGFBR3L) is a pituitary enriched membrane protein selectively detected in gonadotroph cells....

    Anders Jensen Kolnes, Kristin Astrid Berland Øystese, ... Anders Palmstrøm Jørgensen in Pituitary
    Article Open access 23 March 2023
  8. Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours

    Purpose

    Clinically non-functioning pituitary neuroendocrine tumours (NF-PitNETs) present a varying degree of aggressiveness, and reliable prognostic...

    Kristin Astrid B. Øystese, Olivera Casar-Borota, ... Jens Bollerslev in Endocrine
    Article Open access 08 June 2022
  9. Epigenomic and transcriptomic landsca** unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors

    Purpose

    Non-functioning pituitary neuroendocrine tumors are challengingly diagnosed tumors in the clinic. Transsphenoidal surgery remains the...

    B. Aydin, H. Beklen, ... B. Turanli in Journal of Endocrinological Investigation
    Article 28 October 2022
  10. The role of the tumour microenvironment in the angiogenesis of pituitary tumours

    Purpose

    Angiogenesis has been studied in pituitary neuroendocrine tumours (PitNETs), but the role of the tumour microenvironment (TME) in regulating...

    Pedro Marques, Sayka Barry, ... Márta Korbonits in Endocrine
    Article Open access 18 September 2020
  11. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage–tumor interaction axes among different lineages of pituitary neuroendocrine tumors

    Background

    Pituitary neuroendocrine tumors (PitNETs) are common gland neoplasms demonstrating distinctive transcription factors. Although the role of...

    Shaojian Lin, Yuting Dai, ... Zhe Bao Wu in Genome Medicine
    Article Open access 24 April 2024
  12. PIT-EASY survey: validation of the European Pituitary Pathology Group proposal for reporting pituitary neuroendocrine tumors

    The aim of this multicenter prospective survey called PIT-EASY was to assess the relevance of the European Pituitary Pathology Group (EPPG)...

    Maria Francesca Birtolo, Anne Jouinot, ... Chiara Villa in Virchows Archiv
    Article 22 June 2024
  13. Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors

    We aimed to identify the druggable cell-intrinsic vulnerabilities and target-based drug therapies for PitNETs using the high-throughput drug...

    Yijun Cheng, Yuting Dai, ... Zhe Bao Wu in Acta Neuropathologica Communications
    Article Open access 18 April 2024
  14. Circulating non-coding RNA biomarkers of endocrine tumours

    Circulating non-coding RNA (ncRNA) molecules are being investigated as biomarkers of malignancy, prognosis and follow-up in several neoplasms,...

    Henriett Butz, Attila Patócs, Peter Igaz in Nature Reviews Endocrinology
    Article 17 June 2024
  15. Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification

    Since 2017, hormone-negative pituitary neuroendocrine tumors expressing the steroidogenic factor SF1 have been recognized as gonadotroph tumors...

    Francesca Carbonara, Tiziana Feola, ... Marie-Lise Jaffrain-Rea in Endocrine Pathology
    Article Open access 14 December 2023
  16. Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues

    Pituitary neuroendocrine tumours (PitNETs) are neoplasms of the pituitary that overproduce hormones or cause unspecific symptoms due to mass effect....

    Rihards Saksis, Olesja Rogoza, ... Vita Rovite in Cancer Cell International
    Article Open access 11 February 2023
  17. Machine learning models predict delayed hyponatremia post-transsphenoidal surgery using clinically available features

    Purpose

    Delayed hyponatremia (DHN), a unique complication, is the leading cause of unexpected readmission after pituitary surgery. Therefore, this...

    Yutaro Fuse, Kazuhito Takeuchi, ... Ryuta Saito in Pituitary
    Article 30 March 2023
  18. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine

    Nonfuctional pituitary neuroendocrine tumor (NF-PitNET) is highly heterogeneous and generally considered a common intracranial tumor. A series of...

    Siqi Wen, Chunling Li, **anquan Zhan in EPMA Journal
    Article 17 February 2022
  19. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

    Non-tumoural cells within the tumour microenvironment (TME) influence tumour proliferation, invasiveness and angiogenesis. Little is known about TME...

    Pedro Marques, Sayka Barry, ... Márta Korbonits in Acta Neuropathologica Communications
    Article Open access 08 November 2019
  20. Top 10 Nested Pattern Head and Neck Lesions to Notice

    Background

    Nested is defined as “cellular clusters arranged in small grou**s with intervening vascular or stromal networks, lacking lumens or...

    Abberly Lott Limbach, Deborah J. Chute in Head and Neck Pathology
    Article 16 March 2023
Did you find what you were looking for? Share feedback.